Dividend Policy and Shareholder Returns
Dividend History: Kyndryl has no history of paying cash dividends since becoming a public company. The stock’s forward dividend yield is effectively 0% (uk.finance.yahoo.com). Management has prioritized reinvestment and balance sheet flexibility over dividends, given the company’s focus on turnaround efforts and debt management after the spin-off. Instead of dividends, Kyndryl initiated a share repurchase program to return capital to shareholders. The board authorized $700 million of buybacks (announced in two tranches of $300 M in Nov 2024 and $400 M in Nov 2025) (www.sec.gov). Through December 2025, the company had repurchased $254 million of its shares under this program (www.sec.gov) (www.sec.gov), with about $351 M remaining authorized capacity (www.sec.gov) (www.sec.gov). These buybacks were funded in part by available cash and operating cash flow. Notably, Kyndryl’s payout strategy skews toward buybacks rather than dividends – reflecting a desire to balance capital returns with the need to strengthen financials during its multi-year transformation.
Free Cash Flow (AFFO/FFO): Although AFFO/FFO metrics are not applicable to Kyndryl (those are REIT-specific measures), free cash flow (FCF) is a key performance indicator for the company. Kyndryl defines “adjusted free cash flow” in its reporting and had set ambitious goals to grow FCF. For example, at an investor day in 2024 management targeted “tripling free cash flow by 2028” (stockanalysis.com). The company did generate positive FCF of about $291 million in FY2024 (year ended March 31, 2024) (www.marketscreener.com) after several years of cash burn post-separation. However, recent revelations cast doubt on the quality and sustainability of Kyndryl’s FCF. The audit committee’s review (prompted by SEC information requests) found that Kyndryl had been “actively managing working capital” by accelerating customer receipts (e.g. factoring receivables) and delaying supplier payments quarter-to-quarter (even beyond due terms) (www.sec.gov) (www.sec.gov). This standard practice – ongoing since the IBM spin-off – artificially bolstered reported operating cash flow in some periods. For instance, Kyndryl now openly acknowledges deferring certain vendor payments across quarter boundaries (www.sec.gov), meaning some of its touted FCF improvements were achieved via short-term cash management maneuvers rather than underlying growth. The magnitude of these deferrals varied each quarter and was reflected in working capital changes on the balance sheet (www.sec.gov). While management maintains that all such effects were accounted for under U.S. GAAP (www.sec.gov), the practice raises concerns: Kyndryl’s “adjusted free cash flow” may have overstated true sustainable cash generation, an allegation originally leveled by a short-seller in March 2025 (tech.yahoo.com) (tech.yahoo.com). In response, Kyndryl’s new leadership has pledged to improve transparency and internal controls. But until proven otherwise, investors are likely to discount the credibility of the company’s FCF figures. In short, no dividends are expected in the near term, and the onus is on Kyndryl to demonstrate that it can produce real, recurring free cash flow (organically, without aggressive working-capital tricks) before initiating any direct shareholder payouts.
Leverage, Debt Maturities, and Coverage
Capital Structure: As of the latest reported quarter (Dec 31, 2025), Kyndryl carried roughly $3.12 billion of total debt (www.otcmarkets.com) (www.otcmarkets.com). This primarily consists of five tranches of unsecured senior notes assumed at the spin-off or issued subsequently. Key components include a $700 M note due October 2026 (2.05% coupon), $500 M due 2028 (2.70%), $650 M due 2031 (3.15%), $500 M due 2034 (6.35% coupon), and $550 M due 2041 (4.10%) (www.otcmarkets.com) (www.otcmarkets.com). Kyndryl also has about $216 M in finance lease and other obligations (www.otcmarkets.com). The company’s debt maturity profile is fairly well-laddered after a near-term hump in 2026: approximately $805 M of debt comes due within 12 months (mostly the $700 M 2026 bond now classified as current) (www.otcmarkets.com) (www.sec.gov), but no significant maturities occur in 2027 and only $500 M in late 2028, with the bulk of debt maturing in the 2030s. This spacing gives management time to address issues before large principal repayments, although the October 2026 maturity will require attention either via refinancing or use of cash on hand.
Leverage Levels: Kyndryl’s net leverage has been moderate. The company held $1.35 billion in cash at 12/31/2025 (www.sec.gov) against $3.12 B debt, for net debt around $1.77 B (a modest amount relative to its $16 B revenue base). Leading up to the recent turmoil, credit rating agencies viewed Kyndryl’s financial leverage as conservative. Fitch Ratings, for example, affirmed an investment-grade ‘BBB’ rating in late 2024, noting Kyndryl’s “low leverage and elevated cash balances” and commitment to maintain a strong balance sheet (uk.marketscreener.com). Fitch projected that the company’s EBITDA leverage would remain below ~1.5× as margins improve (uk.marketscreener.com) (uk.marketscreener.com). Indeed, through FY2025 Kyndryl had only a mid-single-digit debt-to-EBITDA ratio on a gross basis, and under 2× on a net debt basis, reflecting its IBM spin-off heritage of minimal initial debt. However, it’s important to re-evaluate leverage in light of recent events: if profitability or cash flow erode due to business setbacks or if debt costs rise, effective leverage could tick up. For now, Kyndryl’s balance sheet capacity does not appear to be the most pressing concern – governance and earnings trajectory are bigger issues – but investors should monitor how much debt the company ultimately must add (or cash consume) to navigate its turnaround and any legal liabilities.
Debt Coverage and Interest: Kyndryl’s interest expense is well-covered by earnings at present, thanks to the low coupons on its debt (mostly issued when rates were low). Annual interest payments are roughly ~$100–110 M (blended ~3–4% on $3.1 B debt), while even GAAP operating income should exceed this. In the third quarter of FY2026, for instance, Kyndryl had $168 M in adjusted pretax income and $696 M in adjusted EBITDA (finance.yahoo.com) (finance.yahoo.com), versus perhaps ~$25 M of quarterly interest expense – indicating very healthy coverage. However, two caveats apply: First, earnings quality and predictability are now in question (if internal control problems impede performance, EBITDA could fall). Second, when Kyndryl refinances the $700 M October 2026 notes, its borrowing cost will likely jump from 2.05% to a much higher rate given today’s interest environment and the company’s tarnished credit profile. Ratings agency S&P already placed Kyndryl’s ‘BBB-’ rating on CreditWatch negative, citing “weaker-than-expected results… and rising governance risks” (www.spglobal.com) – a signal that a downgrade to junk (below BBB-) is possible. S&P warned it could cut the rating if Kyndryl’s prospects for “further improvements in free cash flow” wane or if internal-control issues persist (www.spglobal.com). A downgrade would raise Kyndryl’s future borrowing costs. In short, debt is not an immediate crisis – Kyndryl has enough liquidity (>$1.3 B cash) to conceivably repay the 2026 bond if needed (www.sec.gov) (www.otcmarkets.com) – but the margin for error is shrinking. The company must stabilize cash flows before 2026 to avoid refinancing on unfavorable, high-yield terms.
Valuation and Financial Performance
Current Valuation: After the dramatic sell-off in early 2026, Kyndryl’s equity trades at distressed valuation levels. As of mid-2026 the stock price hovers around $12, down roughly 75% year-over-year (uk.finance.yahoo.com). This implies a market capitalization of only ~$2.5 B – about 0.15× annual revenue, an extremely low price/sales multiple for a services company. On a price-to-earnings (P/E) basis the stock is ~10× trailing 12-month earnings (uk.finance.yahoo.com), but this is not very meaningful given the volatility in Kyndryl’s profits. (Notably, trailing earnings were boosted by one-time items like asset sales and aggressive cost actions.) A more appropriate lens may be EV/EBITDA: using enterprise value of ~$4.5 B (market cap plus net debt) and Kyndryl’s adjusted EBITDA run-rate of ~$2.5–2.8 B/year (extrapolating Q3 FY26’s $696 M) (finance.yahoo.com), the stock trades at under 2× EV/EBITDA. This deeply discounted multiple signals that investors doubt the quality and longevity of those earnings. In contrast, healthier IT services peers trade at many times that valuation. The market appears to be pricing in further earnings deterioration or potential financial/reporting troubles – essentially a “show me” discount until Kyndryl proves its turnaround is real.
Performance Trends: Kyndryl’s financial performance has been a mixed bag. Revenue has declined each year since the IBM separation (tech.yahoo.com), reflecting the runoff of low-margin legacy contracts and headwinds from clients moving to cloud providers (uk.marketscreener.com). Management has deliberately repriced or exited unprofitable contracts, which depresses sales in the short term (uk.marketscreener.com) (www.marketscreener.com). The positive side is that profit margins have been gradually improving: adjusted EBITDA margin reached ~18% in the latest quarter (~$696 M on $3.9 B revenue) (finance.yahoo.com), up from low-teens a year ago. Cost-cutting (including workforce “rebalancing” severances) and shifting to higher-value services are yielding some margin expansion (www.marketscreener.com) (www.marketscreener.com). Additionally, Kyndryl’s signings in areas like cloud and digital modernization have shown growth – e.g. the Kyndryl Consult segment delivered double-digit revenue growth in Q3 (finance.yahoo.com), indicating traction in new offerings. Despite these improvements, overall earnings remain slim relative to Kyndryl’s size. GAAP net income was only $57 M for Q3 FY26 (finance.yahoo.com) (a 1.5% net margin), and the company lowered its full-year outlook after that quarter. Fiscal 2026 (year ending Mar 31, 2026) revenue is now expected to decline 2–3% in constant currency (www.spglobal.com), and profit forecasts (for EBITDA and pretax income) were trimmed. This reduced guidance contributed to S&P’s concern about “weaker-than-expected” performance (www.spglobal.com). In summary, Kyndryl’s valuation reflects high skepticism: investors see a contracting topline, only marginal profits, and recent governance issues – a combination warranting a “prove it” valuation despite management’s claims of a budding turnaround.
Risks, Red Flags, and Legal Overhang
Kyndryl faces numerous risks and red flags that have become more pronounced following recent disclosures:
- Internal Control Failures: The most glaring red flag is the admission of “material weaknesses” in internal controls over financial reporting (www.sdxcentral.com) (www.sdxcentral.com). Kyndryl’s audit committee, prompted by an SEC inquiry, found that certain finance functions were deficient – including issues with “information and communication” controls and “tone at the top” (www.sdxcentral.com) (www.sdxcentral.com). In fact, the company stated that management’s prior assessment of internal controls (and PwC’s related audit opinion) for FY2025 “should no longer be relied upon” (www.sdxcentral.com) (www.sdxcentral.com). This is a serious red flag: it implies that for at least a year, Kyndryl’s financial reporting environment was not robust enough to prevent or detect misstatements. Although Kyndryl has said it does not expect to restate past financials (www.theregister.com) (indicating actual GAAP numbers may remain as reported), the weakness in controls raises the risk of errors or misrepresentation. Management is developing a remediation plan and will describe it in the delayed 10-Q filing (uk.finance.yahoo.com), but until those material weaknesses are remediated, investors must question the reliability of Kyndryl’s accounting.
- Executive Departures: In conjunction with the accounting review, Kyndryl’s Chief Financial Officer (David Wyshner) abruptly resigned, as did its General Counsel (Edward Sebold). The company also removed its Global Controller from that role (uk.finance.yahoo.com) (uk.finance.yahoo.com). These were “effective immediately” departures in early Feb 2026, which shocked the market – as evidenced by the stock’s 55% single-day collapse (uk.finance.yahoo.com). The simultaneous exit of both the CFO and chief legal officer is highly unusual and a classic warning sign. As an accounting professor noted, “The red flags are already out – two senior executives responsible for the integrity of financial statements are gone… What does this say about the internal controls of the whole company?” (fortune.com) (fortune.com). Kyndryl installed interim replacements (a long-time IBM/Kyndryl executive, Harsh Chugh, as acting CFO, and Mark Ringes as acting GC) (fortune.com) (www.theregister.com). While this ensures continuity, it underscores that leadership stability is in flux. The risk is that these departures may signal deeper issues – potentially that the CFO and others bore responsibility for the questionable “cash management” practices or disagreed with the board on financial disclosures. It will take time for new permanent leadership to rebuild trust.
- Free Cash Flow Manipulation Allegations: As highlighted by Kuehn Law and others, there are serious allegations that Kyndryl manipulated key financial metrics, particularly free cash flow. A short-seller report (Gotham City Research) in March 2025 alleged Kyndryl “gave the appearance of profits and cash flow while in reality it generated losses and burned cash”, by adjusting EBITDA and free cash flow calculations (tech.yahoo.com) (tech.yahoo.com). Specifically, Gotham claimed Kyndryl has never truly generated positive FCF when calculated realistically (tech.yahoo.com). Kyndryl vehemently denied those accusations at the time (tech.yahoo.com) (tech.yahoo.com). However, the developments since then lend credence to parts of the short-seller’s thesis. The internal review confirmed that management did defer vendor payments to boost reported cash flow from quarter to quarter (www.marketscreener.com) (www.sec.gov). Such “unsustainable cash management practices” are exactly what the lawsuits now claim were misrepresented to investors (www.marketscreener.com). The risk here is multi-fold: (a) Reputation and credibility damage – investors are likely to be skeptical of any “adjusted” metrics Kyndryl reports going forward. (b) Potential SEC enforcement – the SEC’s Division of Enforcement made voluntary document requests (uk.finance.yahoo.com); if they find evidence that investors were misled about liquidity or internal controls, the inquiry could escalate to a formal investigation or penalties. (c) Shareholder litigation – the class action suits (e.g. with a class period Aug 2024–Feb 2026) allege that shareholders suffered losses because Kyndryl painted an overly rosy picture of its turnaround via manipulated FCF and inadequate disclosures (www.marketscreener.com) (www.marketscreener.com). If these suits progress, they could result in costly settlements or judgments. In short, the cloud of legal risk and financial misreporting accusations will hang over Kyndryl for the foreseeable future.
- Business and Execution Risks: Apart from the immediate accounting saga, Kyndryl faces substantial business headwinds. The core risk is secular decline in traditional infrastructure services. As clients migrate workloads to public cloud providers, demand for legacy data-center outsourcing (Kyndryl’s specialty as former IBM Global Technology Services) has been shrinking (uk.marketscreener.com) (www.marketscreener.com). While Kyndryl is pivoting to cloud collaboration and higher-value services, there is no guarantee this will fully offset the decline (www.marketscreener.com). The company’s own outlook of –2% to –3% revenue in FY26 suggests ongoing top-line erosion (www.spglobal.com). Competition is intense (from hyperscalers like Amazon/Microsoft, and from integrators like Accenture or DXC), putting pressure on contract pricing and renewals. Another risk is cost inflation from IBM: Gotham’s report warned that Kyndryl could face an extra $1–2 billion in costs payable to IBM in coming years (tech.yahoo.com) (tech.yahoo.com) – possibly referring to higher expenses as transitional service agreements expire or volume discounts wane. If true, this would squeeze margins unless offset by new efficiencies. Additionally, Kyndryl has been acquiring small companies (e.g. cloud consultancy Solvinity in 2024) (www.theregister.com) to boost capabilities. Integration of acquisitions and realizing synergies pose execution risk. There is also organizational risk given the upheaval: employee morale and retention could suffer amid the scandals, and retaining top technical talent and clients is critical in services. Finally, Kyndryl’s ability to accurately forecast and hit its financial targets is now questionable – management just had to cut guidance and may become more conservative. This uncertainty itself is a risk, as investors hate surprises.
In aggregate, Kyndryl’s situation now combines financial red flags (controls failure, C-suite turnover) with the ongoing strategic risks (market secular decline, turnaround execution) of its business model. This high risk profile is clearly reflected in the stock’s collapse and credit watch status.
Open Questions and Outlook
The path forward for Kyndryl is fraught with questions that investors will be pressing the company to answer:
- How quickly and effectively can the internal control weaknesses be fixed? Kyndryl says it is “proactively addressing” the issue and preparing a remediation plan (uk.finance.yahoo.com). But specifics are needed. Will the company overhaul its finance leadership (beyond the interim CFO) and bring in a “controls-first” CFO as experts advise (fortune.com)? The timeline to remediate material weaknesses can be several quarters; in the interim, Kyndryl will likely receive an adverse audit opinion on internal controls for FY2026. Investors will watch for progress updates: e.g. hiring of an experienced Chief Accounting Officer, new systems or processes implemented, and assurances that the “tone at the top” has changed.
- Were the accounting issues truly limited to working-capital timing, or is there more? Management insists the review relates to “cash management practices and related disclosures” and that no restatement of financial statements is anticipated (www.theregister.com). However, the breadth of the weaknesses (“including but not limited to” certain functions) (www.sdxcentral.com) and the involvement of the SEC raise concern. One open question: Did the SEC’s voluntary request stem from the public short-seller allegations, or did something in Kyndryl’s filings trigger it? Also, the departure of the General Counsel suggests the possibility of issues in legal/compliance processes. Investors will look for reassurance that there are no broader revenue recognition or expense misclassification problems lurking. Any hint of further accounting irregularities would be devastating; conversely, if the issue is confined to the already-disclosed payables timing scheme, that boundary needs to be clearly communicated.
- What is the real, sustainable free cash flow? Now that Kyndryl has explicitly disclosed its practice of deferring vendor payments and selling receivables (www.sec.gov) (www.sec.gov), analysts will adjust their models to strip out those effects. A crucial question is whether Kyndryl can still generate meaningful FCF without leaning on those working capital levers. Management maintained in February that they “do not expect [the accounting review] to impact financial statements” (www.theregister.com), implying that full-year cash flow might ultimately be the same (just differently timed). Nonetheless, going forward Kyndryl may face pressure to curtail aggressive payables deferrals to satisfy auditors and regulators. This could effectively reduce operating cash flow in upcoming quarters (as previously deferred outflows come due). Will Kyndryl’s underlying operations produce enough cash to meet its obligations and fund growth once these tactics are normalized? The answer will shape whether the company truly achieves the envisioned FCF ramp-up, or if it needs to tap external financing. In the next earnings reports, watch for updated free cash flow guidance excluding one-time effects.
- Is the turnaround story still intact? Prior to this crisis, Kyndryl was slowly demonstrating improving signings, margins, and cash flow – the pillars of its turnaround narrative (fortune.com). Now, confidence in management is shaken. As one industry analyst observed, the accounting mess is “jarring in the context of the more positive operational narrative Kyndryl has been communicating” (www.theregister.com). Can the company still deliver on key transformation initiatives (cloud partnerships, AI-driven services, automation, etc.) with credibility? Kyndryl must reassure customers and investors that despite the internal turmoil, the business results are real and continuing to improve. This will likely require transparent metrics: for example, highlighting growth in Kyndryl Consult and digital services, disclosing backlog trends, and perhaps providing segment profitability to show that the new areas are offsetting legacy declines. Additionally, management might need to moderate its long-term targets (e.g. if tripling FCF by 2028 is still realistic or needs revision). Restoring confidence will “depend not just on completing the accounting review, but on demonstrating that the underlying transformation story remains intact” (www.theregister.com). In practical terms, that means posting a few solid, controversy-free quarters where Kyndryl meets guidance and shows stable or growing revenue at improved margins – all while maintaining transparency.
- What are the legal and regulatory outcomes? It is uncertain how the shareholder litigation will play out. If Kyndryl’s board and officers are found to have breached fiduciary duties or violated securities laws, there could be financial consequences (settlements or damages). At minimum, the company will incur legal expenses and management distraction. One open question is whether Kyndryl’s D&O insurance is sufficient to cover a major class-action settlement, should it come to that, or if the company might have to directly bear costs. On the regulatory side, will the SEC’s inquiry close quietly or escalate? Kyndryl says it is cooperating fully and stated it will not comment further due to the ongoing nature (www.theregister.com) – which suggests this is not fully resolved yet. A resolution could range from no action, to a comment letter with recommended improvements, to an enforcement action (if evidence of intentional misstatement is found). Investors should keep an eye on any SEC 8-K filings or disclosures about the status of these investigations.
In conclusion, Kyndryl is at a critical juncture. The company’s underlying business retains significant strengths – a ~$2 billion backlog of long-term infrastructure contracts, global enterprise client relationships, and technical know-how – which give it a platform to succeed if managed well. However, the recent governance lapses and financial engineering have undermined trust in management’s turnaround story. The stock’s collapse and legal scrutiny reflect the market’s demand for accountability and clarity. Going forward, investors will require evidence, not just promises: evidence that internal controls are fixed, that free cash flow is genuinely growing from operating improvements, and that Kyndryl’s modernization strategy can deliver growth without financial gimmicks. Until then, skepticism will remain high – as signaled by Kuehn Law’s call to action for shareholders, it’s a time for investors to remain vigilant and demand transparency from Kyndryl’s leadership (www.marketscreener.com) (www.marketscreener.com). The next few quarters will be pivotal in determining whether Kyndryl can regain credibility and unlock the value of its business, or if further disappointments lie ahead.
